{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:01:19Z","timestamp":1791342079985,"version":"4.3.1"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.molimm.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:20:55Z","timestamp":1678414855000},"page":"111-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2"],"prefix":"10.1016","volume":"156","author":[{"given":"Prabhat K.","family":"Purbey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manash K.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.03.009_bib1","first-page":"361","article-title":"Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study","author":"Achiron","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib3","first-page":"8","article-title":"Complement Evasion Strategies of Viruses: An Overview","author":"Agrawal","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2023.03.009_bib4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the Heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.molimm.2023.03.009_bib5","unstructured":"Aleem, A., Akbar Samad, A.B., Slenker, A.K. , 2022. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). In StatPearls (Treasure Island (FL))."},{"key":"10.1016\/j.molimm.2023.03.009_bib6","doi-asserted-by":"crossref","unstructured":"Alexander, M.R., Dale, B.L., Smart, C.D., Elijovich, F., Wogsland, C.E., Lima, S.M., Irish, J.M., Madhur, M.S. , 2023. Immune Profiling Reveals Decreases in Circulating Regulatory and Exhausted T Cells in Human Hypertension. JACC: Basic to Translational Science.","DOI":"10.1016\/j.jacbts.2022.09.007"},{"key":"10.1016\/j.molimm.2023.03.009_bib7","unstructured":"An, J., Liao, X., Xiao, T., Qian, S., Yuan, J., Ye, H., Qi, F., Shen, C., Liu, Y., Wang, L., et al.\u00a0, 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib8","first-page":"28","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof-of-concept study","author":"Annane","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib9","first-page":"131","article-title":"Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19","author":"Arnold Egloff","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2023.03.009_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116832","article-title":"Central nervous system manifestations of COVID-19: a systematic review","volume":"413","author":"Asadi-Pooya","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molimm.2023.03.009_bib11","first-page":"11","article-title":"Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections","author":"Bajaj","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molimm.2023.03.009_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2020.07.022","article-title":"A hybrid model integrating warm heat and ultraviolet germicidal irradiation might efficiently disinfect respirators and personal protective equipment","volume":"49","author":"Banerjee","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.molimm.2023.03.009_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib14","unstructured":"Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al.\u00a0, 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib15","first-page":"370","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molimm.2023.03.009_bib16","first-page":"318","article-title":"Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches","author":"Bhat","year":"2022","journal-title":"Virus Res."},{"key":"10.1016\/j.molimm.2023.03.009_bib17","first-page":"13","article-title":"COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes","author":"Bigdelou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4614-0106-3_9","article-title":"Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis","volume":"946","author":"Bosmann","year":"2012","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.molimm.2023.03.009_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib20","unstructured":"Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al.\u00a0, 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib21","first-page":"8","article-title":"Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity","author":"Briquez","year":"2022","journal-title":"Sci. Adv."},{"issue":"2908\u20132921","key":"10.1016\/j.molimm.2023.03.009_bib22","article-title":"Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability","volume":"54","author":"Burnett","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2023.03.009_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/d41586-023-00014-3","article-title":"Coronavirus variant XBB.1.5 rises in the United States \u2014 is it a global threat?","volume":"613","author":"Callaway","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.molimm.2023.03.009_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2023.03.009_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.009_bib28","first-page":"12","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nature","author":"Chang","year":"2021","journal-title":"Communications"},{"key":"10.1016\/j.molimm.2023.03.009_bib29","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"130","author":"Channappanavar","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2023.03.009_bib30","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"129","author":"Channappanavar","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2023.03.009_bib31","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2023.03.009_bib32","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"10.1016\/j.molimm.2023.03.009_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.molimm.2023.03.009_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/infdis\/jiab330","article-title":"Early convalescent plasma therapy and mortality among US Veterans Hospitalized With Nonsevere COVID-19: an observational analysis emulating a target trial","volume":"224","author":"Cho","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib35","first-page":"2","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Reports","author":"Cohen","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cell.2006.02.001","article-title":"The evolution of adaptive immune systems","volume":"124","author":"Cooper","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1164\/rccm.202108-1859OC","article-title":"Anti-granulocyte\u2013macrophage colony\u2013stimulating factor monoclonal antibody gimsilumab for covid-19 pneumonia: a randomized, double-blind, placebo-controlled trial","volume":"205","author":"Criner","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.009_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/infdis\/jiab176","article-title":"Differential T-cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers","volume":"224","author":"da Silva Antunes","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib40","article-title":"Long COVID: major findings, mechanisms and recommendations","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2023.03.009_bib41","first-page":"11","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","author":"De Biasi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2023.03.009_bib42","first-page":"23","article-title":"Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial","author":"De Leeuw","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.molimm.2023.03.009_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib44","first-page":"11","article-title":"Reduction and Functional Exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Disco"},{"key":"10.1016\/j.molimm.2023.03.009_bib46","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molimm.2023.03.009_bib47","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2016-06-719823","article-title":"BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations","volume":"129","author":"Duggan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2023.03.009_bib48","first-page":"5","article-title":"Viruses are a dominant driver of protein adaptation in mammals","author":"Enard","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.molimm.2023.03.009_bib49","first-page":"3","article-title":"Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes. Cell Reports","author":"Faustman","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.009_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7150\/ijms.67815","article-title":"Potential genes associated with COVID-19 and comorbidity","volume":"19","author":"Feng","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.molimm.2023.03.009_bib52","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2023.03.009_bib53","first-page":"22","article-title":"Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis","author":"Gan","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1932","article-title":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molimm.2023.03.009_bib55","unstructured":"Gao, T., Hu, M., Zhang, X., Li, H., Zhu, L., Liu, H., Dong, Q., Zhang, Z., Wang, Z., Hu, Y., et al. (2020b)."},{"key":"10.1016\/j.molimm.2023.03.009_bib56","unstructured":"Gong, J., Dong, H., Xia, S.Q., Huang, Y.Z., Wang, D., Zhao, Y., Liu, W., Tu, S., Zhang, M., Wang, Q.,\u00a0Lu, F. , 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib57","first-page":"12","article-title":"The BCG vaccine for COVID-19: first verdict and future directions","author":"Gonzalez-Perez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib59","first-page":"9","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.molimm.2023.03.009_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2023.03.009_bib62","first-page":"10","article-title":"Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies","author":"Guo","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.molimm.2023.03.009_bib63","first-page":"18","article-title":"SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export","author":"Haagmans","year":"2022","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.molimm.2023.03.009_bib64","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1073\/pnas.1921485117","article-title":"Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors","volume":"117","author":"Hackbart","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molimm.2023.03.009_bib65","doi-asserted-by":"crossref","unstructured":"Hamiel, U., Kozer, E.,\u00a0Youngster, I. , 2020. SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults. Jama.","DOI":"10.1001\/jama.2020.8189"},{"key":"10.1016\/j.molimm.2023.03.009_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjmed.2021.07.035","article-title":"Updates on hydroxychloroquine in prevention and treatment of COVID-19. The","volume":"135","author":"Hennekens","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib67","doi-asserted-by":"crossref","unstructured":"Henry, B.M., and Lippi, G. (2020). Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol.","DOI":"10.1007\/s11255-020-02451-9"},{"key":"10.1016\/j.molimm.2023.03.009_bib68","first-page":"46","article-title":"Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19","author":"Hermine","year":"2022","journal-title":"pneumonia: A Random Clin. Trial CORIMUNO-19 Study Group. eClinicalMedicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","author":"Hirano","year":"2020","journal-title":"Immunity"},{"issue":"271\u2013280","key":"10.1016\/j.molimm.2023.03.009_bib70","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000513288","article-title":"The association between presence of comorbidities and COVID-19 severity: a systematic review and meta-analysis","volume":"50","author":"Honardoost","year":"2021","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41588-021-01006-7","article-title":"Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease","volume":"54","author":"Horowitz","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2023.03.009_bib73","first-page":"91","article-title":"The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-Mediated RIG-I ubiquitination","author":"Hu","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2023.03.009_bib74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.009_bib75","doi-asserted-by":"crossref","unstructured":"Iwasaki, A., Yang, Y.2020. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol.","DOI":"10.1038\/s41577-020-0321-6"},{"key":"10.1016\/j.molimm.2023.03.009_bib76","unstructured":"Jiang, H.-w, Li, Y., Zhang, H.-n, Wang, W., Men, D., Yang, X., Qi, H., Zhou, J., and Tao, S.-c (2020)."},{"key":"10.1016\/j.molimm.2023.03.009_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.molimm.2023.03.009_bib78","first-page":"21","article-title":"DNA damage contributes to age\u2010associated differences in SARS\u2010CoV\u20102 infection","author":"Jin","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib79","first-page":"12","article-title":"Virology, Epidemiology, Pathogenesis, and Control of COVID-19","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.molimm.2023.03.009_bib80","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000503030","article-title":"Innate Immune Evasion by Human Respiratory RNA Viruses","volume":"12","author":"Kikkert","year":"2020","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.molimm.2023.03.009_bib83","first-page":"55","article-title":"Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development","author":"Kim","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib84","first-page":"61","article-title":"GM-CSF targeting in COVID-19: an approach based on fragile foundations","author":"Kohler","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.molimm.2023.03.009_bib85","first-page":"6","article-title":"Severely ill patients with COVID-19 display impaired exhaustion features in SARS-CoV-2\u2013reactive CD8+ T cells. Science","author":"Kusnadi","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2023.03.009_bib86","doi-asserted-by":"crossref","unstructured":"Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., and Xu, H. (2020). Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA.","DOI":"10.1001\/jama.2020.2783"},{"key":"10.1016\/j.molimm.2023.03.009_bib87","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","article-title":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection","volume":"191","author":"Lau","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib88","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S1473-3099(22)00502-3","article-title":"Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial","volume":"22","author":"Lazarus","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib89","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib90","doi-asserted-by":"crossref","unstructured":"Li, X., Geng, M., Peng, Y., Meng, L., and Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal.","DOI":"10.1016\/j.jpha.2020.03.001"},{"key":"10.1016\/j.molimm.2023.03.009_bib91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.virol.2007.07.015","article-title":"Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection","volume":"368","author":"Libraty","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2023.03.009_bib92","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults","volume":"384","author":"Libster","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib93","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2249.2005.02864.x","article-title":"Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity","volume":"141","author":"Lin","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib94","first-page":"13","article-title":"A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature","author":"Liu","year":"2022","journal-title":"Communications"},{"key":"10.1016\/j.molimm.2023.03.009_bib95","unstructured":"Lokugamage, K.G., Hage, A., Schindewolf, C., Rajsbaum, R.,\u00a0Menachery, V.D. 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib96","doi-asserted-by":"crossref","unstructured":"Long, Q.X., Liu, B.Z., Deng, H.J., Wu, G.C., Deng, K., Chen, Y.K., Liao, P., Qiu, J.F., Lin, Y., Cai, X.F., et al. 2020. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med.","DOI":"10.1038\/s41591-020-0897-1"},{"key":"10.1016\/j.molimm.2023.03.009_bib97","unstructured":"Lukassen, S., Chua, R.L., Trefzer, T., Kahn, N.C., Schneider, M.A., Muley, T., Winter, H., Meister, M., Veith, C., Boots, A.W., et al. 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib98","first-page":"4","article-title":"Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis","author":"Ma","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molimm.2023.03.009_bib99","doi-asserted-by":"crossref","unstructured":"Magro, C., Mulvey, J.J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A.,\u00a0Laurence, J.2020. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res.","DOI":"10.1016\/j.trsl.2020.04.007"},{"key":"10.1016\/j.molimm.2023.03.009_bib100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jiph.2021.12.014","article-title":"The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges","volume":"15","author":"Malik","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.molimm.2023.03.009_bib101","unstructured":"Manry, J., Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Michailidis, E., Hoffmann, H.-H., Eto, S., Garcia-Prat, M., et al. 2022. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proceedings of the National Academy of Sciences 119."},{"key":"10.1016\/j.molimm.2023.03.009_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.molimm.2023.03.009_bib103","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2023.03.009_bib104","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1080\/07391102.2021.1894986","article-title":"A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein","volume":"40","author":"Martin","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molimm.2023.03.009_bib105","doi-asserted-by":"crossref","unstructured":"McGonagle, D., O'Donnell, J.S., Sharif, K., Emery, P.,\u00a0Bridgewood, C.2020. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. The Lancet Rheumatology.","DOI":"10.1016\/S2665-9913(20)30121-1"},{"key":"10.1016\/j.molimm.2023.03.009_bib106","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib107","doi-asserted-by":"crossref","unstructured":"Miller, A.R., Mac & Fasciglione, Kimberly & Roumenova, Violeta & Li, Yan & Otazu, Gonzalo. 2020. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv preprint.","DOI":"10.1101\/2020.03.24.20042937"},{"key":"10.1016\/j.molimm.2023.03.009_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.molimm.2023.03.009_bib109","first-page":"5","article-title":"SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. Communications","author":"Miyamoto","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.molimm.2023.03.009_bib110","first-page":"9","article-title":"Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection","author":"Mu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","article-title":"Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost","volume":"607","author":"Muecksch","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib112","unstructured":"Muus, C., Luecken, M.D., Eraslan, G., Waghray, A., Heimberg, G., Sikkema, L., Kobayashi, Y., Vaishnav, E.D., Subramanian, A., Smilie, C., et al. 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib113","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib114","doi-asserted-by":"crossref","unstructured":"Netea, M.G., Dom\u00ednguez-Andr\u00e9s, J., Barreiro, L.B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L.A.B., van der Meer, J.W.M., Mhlanga, M.M., Mulder, W.J.M., et al. (2020). Defining trained immunity and its role in health and disease. Nature Reviews Immunology.","DOI":"10.1038\/s41577-020-0285-6"},{"key":"10.1016\/j.molimm.2023.03.009_bib115","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.03.009_bib116","first-page":"61","article-title":"A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)","author":"Patel","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.molimm.2023.03.009_bib117","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2023.03.009_bib118","doi-asserted-by":"crossref","unstructured":"Peeples, L.2020. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proceedings of the National Academy of Sciences 117, 8218\u20138221.","DOI":"10.1073\/pnas.2005456117"},{"key":"10.1016\/j.molimm.2023.03.009_bib119","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19","author":"Perricone","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2023.03.009_bib121","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2023.03.009_bib122","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib123","unstructured":"Qamar et al., 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib124","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib125","doi-asserted-by":"crossref","unstructured":"Redelman-Sidi, G. (2020). Could BCG be used to protect against COVID-19? Nature Reviews Urology.","DOI":"10.1038\/s41585-020-0325-9"},{"key":"10.1016\/j.molimm.2023.03.009_bib126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","article-title":"Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5","volume":"5","author":"Reikine","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib127","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8+ T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib128","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2023.03.009_bib129","first-page":"121","article-title":"COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles\u2019 heel conserved region to minimize probability of escape mutations and drug resistance","author":"Robson","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death","volume":"3","author":"Rock","year":"2008","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.molimm.2023.03.009_bib131","first-page":"20","article-title":"Autoimmunity is a hallmark of post-COVID syndrome","author":"Rojas","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2023.03.009_bib133","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.3748\/wjg.v27.i46.7925","article-title":"COVID-19 and gut immunomodulation","volume":"27","author":"Roy","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molimm.2023.03.009_bib134","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 Receptor Inhibition in Covid-19 \u2014 cooling the Inflammatory Soup","volume":"384","author":"Rubin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib136","first-page":"14","article-title":"Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals","author":"Saksena","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib137","unstructured":"Salazar, E., Perez, K.K., Ashraf, M., Chen, J., Castillo, B., Christensen, P.A., Eubank, T., Bernard, D.W., Eagar, T.N., Long, S.W., et al. 2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib138","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.molpharmaceut.0c00608","article-title":"COVID-19 transmission, current treatment, and future therapeutic strategies","volume":"18","author":"Salian","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molimm.2023.03.009_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.molimm.2023.03.009_bib140","first-page":"19","article-title":"COVID\u201019 is an emergent disease of aging","author":"Santesmasses","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib141","doi-asserted-by":"crossref","unstructured":"Sanyal and K. Paul (2021). Organoid Technology and the COVID Pandemic. In SARS-CoV-2 Origin and COVID-19 Pandemic Across the Globe.","DOI":"10.5772\/intechopen.98542"},{"key":"10.1016\/j.molimm.2023.03.009_bib142","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T Cell Response to Respiratory Virus Infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib143","doi-asserted-by":"crossref","unstructured":"Schuhenn, J., Meister, T.L., Todt, D., Bracht, T., Schork, K., Billaud, J.-N., Elsner, C., Heinen, N., Karakoese, Z., Haid, S., et al. 2022. Differential interferon-\u03b1 subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences 119.","DOI":"10.1101\/2021.05.20.444757"},{"key":"10.1016\/j.molimm.2023.03.009_bib144","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0300060513516944","article-title":"Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus","volume":"42","author":"Sefil","year":"2014","journal-title":"J. Int Med Res"},{"issue":"158\u2013168","key":"10.1016\/j.molimm.2023.03.009_bib146","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2023.03.009_bib147","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41568-019-0209-6","article-title":"The pro-tumorigenic host response to cancer therapies","volume":"19","author":"Shaked","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molimm.2023.03.009_bib148","first-page":"7","article-title":"ACE2-independent infection of T lymphocytes by SARS-CoV-2","author":"Shen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molimm.2023.03.009_bib149","doi-asserted-by":"crossref","unstructured":"Sheridan, C.2020. Convalescent serum lines up as first-choice treatment for coronavirus. Nat Biotechnol.","DOI":"10.1038\/d41587-020-00011-1"},{"key":"10.1016\/j.molimm.2023.03.009_bib150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical\u2013therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.molimm.2023.03.009_bib151","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa2031304","article-title":"A randomized trial of convalescent plasma in Covid-19 severe pneumonia","volume":"384","author":"Simonovich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib152","first-page":"8","article-title":"Complement C3 inhibition in severe COVID-19 using compstatin AMY-101","author":"Skendros","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molimm.2023.03.009_bib153","first-page":"13","article-title":"Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. Nature","author":"Smith","year":"2022","journal-title":"Communications"},{"key":"10.1016\/j.molimm.2023.03.009_bib154","first-page":"20","article-title":"A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients","author":"Soltani-Zangbar","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.molimm.2023.03.009_bib155","doi-asserted-by":"crossref","unstructured":"Son, K., Jamil, R., Chowdhury, A., Mukherjee, M., Venegas, C., Miyasaki, K., Zhang, K., Patel, Z., Salter, B., Yuen, A.C.Y., et al.\u00a0, 2022. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. European Respiratory Journal.","DOI":"10.1183\/13993003.00970-2022"},{"key":"10.1016\/j.molimm.2023.03.009_bib156","first-page":"10","article-title":"Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: a multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)","author":"Song","year":"2022","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.molimm.2023.03.009_bib157","first-page":"11","article-title":"Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nature","author":"Song","year":"2020","journal-title":"Communications"},{"key":"10.1016\/j.molimm.2023.03.009_bib158","unstructured":"Srivastava, S., Verma, S., Kamthania, M., Kaur, R., Badyal, R.K., Saxena, A.K., Shin, H.-J., Kolbe, M.,\u00a0Pandey, K.C.2020."},{"key":"10.1016\/j.molimm.2023.03.009_bib159","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2023.03.009_bib160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.molimm.2023.03.009_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","author":"Sungnak","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.molimm.2023.03.009_bib162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2023.03.009_bib163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.molimm.2023.03.009_bib164","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.molimm.2023.03.009_bib166","first-page":"40","article-title":"SARS\u2010CoV\u20102 sensing by RIG\u2010I and MDA5 links epithelial infection to macrophage inflammation. The","author":"Thorne","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2023.03.009_bib167","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fimmu.2019.00672","article-title":"Complement Therapeutics in Autoimmune Disease","volume":"10","author":"Thurman","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib168","first-page":"48","article-title":"Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled","author":"Upton","year":"2022","journal-title":"phase 3 Trial eClinicalMedicine"},{"key":"10.1016\/j.molimm.2023.03.009_bib169","first-page":"9","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","author":"van de Veerdonk","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.molimm.2023.03.009_bib170","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-022-02851-0","article-title":"China and India approve nasal COVID vaccines \u2014 are they a game changer?","volume":"609","author":"Waltz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib171","doi-asserted-by":"crossref","unstructured":"Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA.","DOI":"10.1001\/jama.2020.1585"},{"key":"10.1016\/j.molimm.2023.03.009_bib172","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1128\/JVI.03273-12","article-title":"A case for the ancient origin of coronaviruses","volume":"87","author":"Wertheim","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2023.03.009_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib174","unstructured":"Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020)."},{"key":"10.1016\/j.molimm.2023.03.009_bib175","first-page":"25","article-title":"Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020","author":"Xing","year":"2020","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.molimm.2023.03.009_bib176","doi-asserted-by":"crossref","unstructured":"Xing, Y., Ni, W., Wu, Q., Li, W., Li, G., Tong, J., Song, X., and Xing, Q. (2020b).","DOI":"10.1155\/2020\/8811516"},{"key":"10.1016\/j.molimm.2023.03.009_bib177","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J. Oral. Sci."},{"key":"10.1016\/j.molimm.2023.03.009_bib178","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.molimm.2023.03.009_bib179","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.molimm.2023.03.009_bib180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.molimm.2023.03.009_bib181","first-page":"22","article-title":"Does genetic predisposition contribute to the exacerbation of COVID-19 Symptoms in individuals with comorbidities and explain the huge mortality disparity between the east and the west?","author":"Yamamoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2023.03.009_bib182","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","article-title":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China","volume":"80","author":"Yang","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.molimm.2023.03.009_bib183","first-page":"34","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","author":"Yin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.molimm.2023.03.009_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.molimm.2023.03.009_bib185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.molimm.2023.03.009_bib186","unstructured":"Zhang, D., Guo, R., Lei, L., Liu, H., Wang, Y., Wang, Y., Dai, T., Zhang, T., Lai, Y., Wang, J., et al. (2020)."},{"key":"10.1016\/j.molimm.2023.03.009_bib187","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2023.03.009_bib188","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2214\/AJR.20.22976","article-title":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study","volume":"214","author":"Zhao","year":"2020","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.molimm.2023.03.009_bib189","unstructured":"Zhao, X., Zhang, B., Li, P., Ma, C., Gu, J., Hou, P., Guo, Z., Wu, H., and Bai, Y. (2020c)."},{"key":"10.1016\/j.molimm.2023.03.009_bib190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.03.009_bib191","unstructured":"Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., qi, Y., Sun, R., Tian, Z., Xu, X., and Wei, H. (2020b)."},{"key":"10.1016\/j.molimm.2023.03.009_bib192","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.molimm.2023.03.009_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","author":"Ziegler","year":"2020","journal-title":"Cell"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:45:54Z","timestamp":1758980754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":193,"alternative-id":["S0161589023000524"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.03.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}